About Biobot Surgical
Biobot Surgical is a Healthcare company based in Singapore (Singapore) founded in 2010 by Yap Chew Loong and Ng Wan Sing. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Biobot Surgical has raised $25.75 million across 2 funding rounds from investors including Tony Tan, ZIG Ventures and Temasek. Its chief executive, as recorded, is Deli Li. Biobot Surgical offers products and services including Mona Lisa. Its focus areas include Life Sciences, Surgical Instruments, Robotic Surgery and High Tech. Its legal entity is BIOBOT SURGICAL PTE LTD.
Company details
Developer of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin.
- Headquarters Singapore, Singapore
- Founders Yap Chew Loong, Ng Wan Sing
- SectorsHealthcareIndustrial Goods & Manufacturing
- Website biobotsurgical.com
- Social LinkedIn X Facebook YouTube
- Legal Name Biobot Surgical Pte Ltd
- Total Equity Funding$25.75M (USD)
in 2 rounds
- Latest Funding Round$7.85M (USD), Series C
Apr 2026
- InvestorsZIG Ventures
& 3 more
Products & Services of Biobot Surgical
Biobot Surgical offers a comprehensive portfolio of products and services, including Mona Lisa.
Provides accurate robotic assistance for prostate biopsies and treatments.
Apps and channels of Biobot Surgical
its YouTube channel Biobot Surgical Pte Ltd has 110 subscribers and 6 videos.
Videos from Biobot Surgical
The most watched videos on Biobot Surgical's YouTube channel, Biobot Surgical Pte Ltd (110 subscribers). Click a video to play it here.
More on Biobot Surgical Pte Ltd.
Funding Insights of Biobot Surgical
Biobot Surgical has successfully raised a total of $25.75M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $7.85 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25.75M
- Total Rounds 2
- Last Round Series C — $7.85M
- First Round $17.9M
(Mar 2024)
- Investors Count 4
All 2 funding rounds of Biobot Surgical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | $7.85M | Series C | – | Clavystbio | |
| Mar 2024 | $17.9M | Series B | – | Tony Tan |
4 investors in total: 3 institutional and 1 angel.
Investors in Biobot Surgical
Biobot Surgical has secured backing from 4 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Tony Tan, ZIG Ventures and Temasek.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ZIG Ventures is focused on healthcare innovation investments. | 2019 | ziggroup.com.sg | Singapore, Singapore | |
| temasek.com.sg | ||||
| clavystbio.com | ||||
TT Tony Tan | Indian angel investor, focuses on early-stage tech startups | unknown_50d3447d59c743be8 |
Investor details for Biobot Surgical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biobot Surgical
8 people are tracked at Biobot Surgical (6 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Yap Chew Loong | Founder | Leadership |
Ng Wan Sing | Founder | Leadership |
Deli Li | CEO | Leadership |
Delhi Li | CEO | Leadership |
Derrick Yong | Co-chief Engineer | Leadership |
Giansante Alessandrini | Commercial Director EMEA | Leadership |
Michael Booth | Sales Manager - Southeast | Team |
Biobot Surgical Group | Marketing Staff | Team |
Complete people profiles for Biobot Surgical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biobot Surgical
3 dated milestones of Biobot Surgical across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Biobot Surgical is founded.
- Funding First funding round of $17.9M.
- Funding Latest funding round, Series C, of $7.8M.
Web traffic of Biobot Surgical
The website of Biobot Surgical (biobotsurgical.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 1.2% vs previous month
Websites whose visitors overlap most with Biobot Surgical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biobot.io | 100% | 8.5K | #2,240,856 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biobot Surgical
Complete news archive for Biobot Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biobot Surgical
Biobot Surgical was founded in 2010 and raised its 1st funding round 14 years after it was founded.
Biobot Surgical is headquartered in Singapore, Singapore.
Deli Li is the CEO of Biobot Surgical, as recorded in our data.
Biobot Surgical is a funded company, having raised a total of $25.75M across 2 funding rounds to date. The company's 1st funding round was a Series B of $17.9M, raised on Mar 2024.
Developer of surgical automation devices. The products include robotic transperineal biopsy device (rTPB), developed through collaborative partnership that enables surgeons to extract prostate biopsy tissues through 2 small needle puncture incisions on the perineal skin.
Biobot Surgical offers Mona Lisa.
Biobot Surgical has 4 investors. Key investors include Tony Tan, ZIG Ventures, Temasek, and ClavystBio.
Biobot Surgical operates through Biobot Surgical Pte Ltd.